This is a daily watchlist for short-term trading: I might trade all/none of the stocks listed, and even stocks not listed! I am targeting potentially good candidates for short-term trading; I have no opinion on them as investments. The potential of the stock moving today is what makes it interesting, everything else is secondary.
I don't know how sustained today's move will be- we've made a massive move upwards, and even 30% tariffs will still reduce business with China by 70% in the medium term (\~6 to 9 month timeframe)
News: [Us And China Agree To Major Reductions In Tariffs For 90 Days](https://www.bloomberg.com/news/articles/2025-05-12/us-and-china-agree-to-major-reductions-in-tariffs-for-90-days)
[**AAPL (Apple)**](https://finviz.com/quote.ashx?t=AAPL&p=d) **/** [**AMZN (Amazon)**](https://finviz.com/quote.ashx?t=AMZN&p=d)\- Both stocks are up \~6% following announcement of a 90-day suspension of U.S.-China tariffs, reducing U.S. tariffs on Chinese imports from 145% to 30%. Watching $214/$215 in AAPL and seeing if we can make another move higher. Currently long. Obviously this is a 90-day suspension and not actually a guarantee that things will return back to normal. Everything in consumer disc is moving off this news. Risks I'm seeing from this are potential re-escalation of trade tensions and more supply chain disruptions, and I'm thinking of possibly flipping short if we make a massive move upwards.
[**BABA (Alibaba)**](https://finviz.com/quote.ashx?t=BABA&p=d) **/** [**JD (JD.com)**](https://finviz.com/quote.ashx?t=JD&p=d)\- Chinese tech stocks like BABA and JD are also major winners of tariffs, with both up roughly 6%, following the 90-day agreement. Watching $135 level (basically just seeing which Chinese stocks are close to breaking highs). Risks are the same as American stocks. Other notable stocks I like on this are BIDU/TCEHY (trades OTC)
[**PFE (Pfizer)**](https://finviz.com/quote.ashx?t=PFE&p=d) **/** [**MRK (Merck)**](https://finviz.com/quote.ashx?t=MRK&p=d) **/** [**JNJ (Johnson & Johnson)**](https://finviz.com/quote.ashx?t=JNJ&p=d)\- Trump announced plans to sign an executive order implementing a "most-favored-nation" policy to reduce U.S. prescription drug prices by up to 59%. This policy aims to "align" U.S. drug prices with the lower prices paid by other countries. Obviously pretty terrible news for anyone investing in pharmaceutical stocks because it affects major revenue sources for this company. The US has limited direct negotiating and mainly relies on private pharmacy benefit managers to negotiate prices in insurance plans currently, which results in sky-high insurance costs. I'm Interested in MRK, we're already broken lows (even during the tariffs) because MRK is highly dependent on Medicare reimbursement (MRK).
[**BP (BP)**](https://finviz.com/quote.ashx?t=BP&p=d)\- BP up on reports that several major oil companies, including Shell, Chevron, and ExxonMobil, are evaluating potential takeover bids. BP is considered undervalued, with a market cap of £57B against asset valuations of \~£120B. No levels I'm watching at this time. Notably, the last piece of meaningful news on this that I remember was Eliot Management taking a stake, so it pushes the likelihood that they're getting acquired up incrementally.